Summary
The effect of diltiazem on the oxymyoglobin level was studied in the isolated rat heart during hypoxia. The heart was perfused with Krebs-Henseleit solution equilibrated with a gas mixture containing 95% O2+5% CO2 (normoxic perfusion solution) at a constant flow rate (9 ml/min) according to Langendorff's method. All the hearts were paced at 300 beats/min. The myocardial oxymyoglobin level (i.e., intracellular oxygen level) of the left ventricular surface was continuously measured by means of an optical technique. Diltiazem (infused into the aortic cannula for 10 minutes at concentrations of 0.72, 2.41, or 4.82 μM, expressed as the final concentration in the solution) decreased, the left ventricular pressure (LVP) and perfusion pressure (PP) dose dependently, and did not change the oxymyoglobin (MbO2) level during normoxic perfusion. Hypoxic perfusion (using a gas mixture containing 30% O2+5% CO2+65% N2) decreased the MbO2, LVP, and PP. Diltiazem (infused 5 minutes after the hypoxic perfusion) at a concentration of 2.41 or 4.82 μM increased the MbO2 level and further decreased the LVP, without affecting the PP. The low concentration (0.72 μM) of diltiazem, however, had practically no effect on these parameters. In summary, diltiazem in high concentrations decreased the LVP and increased the intracellular oxygen level of the myocardial cells during hypoxia, but not during normoxia.
Similar content being viewed by others
References
Watanabe K, Kimura Y, Abiko Y. Nifedipine increases oxygen saturation level of myoglobin in the rat heart during hypoxia.Arch Int Pharmacodyn Ther 1986;284:297–312.
Hara A, Matsumura H, Abiko Y. Effect of nisoldipine on the oxymyoglobin level of myocardial cells in hypoxie, perfused rat hearts.Arch Int Pharmacodyn Ther 1989;298:78–89.
Sato M, Nagao T, Yamaguchi I, Nakajima H. Pharmacological studies on a 1,5-benzothiazepine derivative (CRD-401) I. Cardiovascular actions.Arzneim Forsch 1971;21:1338–1343.
Millard RW, Lathrop DA, Grupp G, et al. Differential cardiovascular effects of calcium channel blocking agents: Potential mechanisms.Am J Cardiol 1982;49:499–506.
Taira N. Differences between dihydropyridine and non-dihydropyridine calcium antagonists in inotropic, chronotropic, dromotropic and vascular effects: Differences in underlying mechanism. In: Fleckenstein A, van Breemen C, Gross R, Hoffmeister F, eds.Cardiovascular Effects of Dihydropyridine-Type Calcium Antagonists and Agonists, Heidelberg: Springer-Verlag, 1985;370–378.
Tamura M, Oshino N, Chance B, Silver IA. Optical measurements of intracellular oxygen concentration of rat heart in vitro.Arch Biochem Biophys 1978;191:8–22.
Stryer L.Biochemistry. San Francisco: Freeman and Company, (Tokyo: Toppan Company), 1975:73–91.
Opie, LH, Singh BN. Calcium channel antagonists (slow channel blockers). In: Opie LH, ed.Drugs for the heart. London: Grune & Stratton, 1987:34–53.
Lavanchy N, Martin J, Rossi A. Effect of diltiazem on the energy metabolism of the isolated rat heart submitted to ischemia: A31PNMR study.J Mol Cell Cardiol 1986;18:931–941.
Nakazawa M, Tamatsu H, Tsuchihashi H, et al. Beneficial effects of diltiazem on the ischemic derangements of the myocardial metabolism assessed by31P-NMR in the isolated perfused rat heart.Jpn J Pharmacol 1985;39:51–58.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsumura, H., Hara, A. & Abiko, Y. Effect of diltiazem on the oxymyoglobin level of myocardial cells in the isolated, perfused rat heart during hypoxia. Cardiovasc Drug Ther 4, 719–722 (1990). https://doi.org/10.1007/BF01856560
Issue Date:
DOI: https://doi.org/10.1007/BF01856560